Insider Transactions in Q2 2022 at Transcode Therapeutics, Inc. (RNAZ)
Insider Transaction List (Q2 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 16
2022
|
Thomas A Fitzgerald Interim CEO, CFO |
BUY
Open market or private purchase
|
Direct |
12,000
+7.93%
|
$12,000
$1.27 P/Share
|
|
May 31
2022
|
Robert Michael Dudley Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
2,000
+0.23%
|
$2,000
$1.87 P/Share
|
|
May 27
2022
|
Robert Michael Dudley Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
28,000
+3.11%
|
$28,000
$1.84 P/Share
|